Admission Date:  [**2117-10-28**]              Discharge Date:   [**2117-10-30**]  Date of Birth:  [**2067-12-26**]             Sex:   F  Service: NEUROSURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1271**] Chief Complaint: Fall  Major Surgical or Invasive Procedure: none   History of Present Illness: Ms. [**Known lastname 20780**] is a 49 year old woman with PMH meningioma s/p subtotal resection and IMRT radiation 6 years ago and currently on protocol medication C8D1C8D1 SOM230C for recurrent grade I parasagital meningioma who presents after mechanical fall.
Asymptomatic prior to fall, but with headache, lightheadedness, nausea and vomiting after fall.
No associated neurologic complaints- no visual changes/numbness/tingling/weakness.
Past Medical History: -grade I parasagital meningioma s/p subtotal resection and IMRT radiation; now with recurrence and on protocol drug -hysterectomy for fibroids -gastritis -hiatal hernia   Social History: Lives with boyfriend.
Family History: Mother died at 44 of stomach cancer, father died at 68 of a heart attack.
She has no brothers or sisters   Physical Exam: On Admission: vitals:  T: 97.3  BP: 106/72  HR: 68 R:14   O2Sats: 100% on 2L NC Gen: WD/WN, comfortable, NAD.
HEENT: PERRL, EOMI, MMM, no oral lesions Neck: Supple.
No dysarthria or paraphasic errors.
No abnormal movements, tremors.
The patient was able to ambulate independently with a steady gait.
FINDINGS: A subdural hemorrhage is seen along the left convexity measuring up to approximately 6 mm with up to 5-mm rightward shift from normally midline structures.
There is no evidence of acute fracture.
Encephalomalacia is seen within the right frontal lobe, not significantly changed since [**2117-2-26**] and may be related to postoperative changes.
IMPRESSION: Left subdural hemorrhage with rightward mildine shift of 5 mm, not significantly changed since CT earlier today.
CT HEAD W/O CONTRAST Study Date of [**2117-10-29**] 12:14 AM Final Report INDICATION: 29-year-old female with traumatic subdural hemorrhage status post fall, here for evaluation of stability.
FINDINGS: Compared to one day prior, there is no significant change of an 8-mm subdural hematoma along the left hemicalvarial concavity.
There is no evidence of increased mass effect.
There is no new focus of hemorrhage.
IMPRESSION: Overall stable appearance of a left-sided subdural hemorrhage as compared to one day prior, without increased mass effect or new focus of hemorrhage.
Dr. [**Last Name (STitle) 724**] was consulted about the potential side effects of her chemothrapy and she was started on Dilantin for seizure prophylaxis.
On the morning of [**10-29**] she complained of some right foot weakness.
In addition, since her hospital stay, she had transiently elevated blood sugars that resolved without treatment it was recommended that she follow up with her primary care physician regarding her hyperglycemia.
Disp:*30 Tablet(s)* Refills:*0* 4. oxycodone 5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain for 1 weeks: do not drive while taking this medication, do not take if lethargic.
Exercise should be limited to walking; no lifting, straining, or excessive bending.
Increase your intake of fluids and fiber, as narcotic pain medicine can cause constipation.
You have been prescribed Dilantin (Phenytoin) for anti-seizure medicine, take it as prescribed and follow up with laboratory blood drawing in one week.
New onset of tremors or seizures.
Any confusion, lethargy or change in mental status.
Any numbness, tingling, weakness in your extremities.
Pain or headache that is continually increasing, or not relieved by pain medication.
New onset of the loss of function, or decrease of function on one whole side of your body.
Your finger stick glucose was transiently elevated and resolved on its own during your hospital stay.
Please follow up with your primary care physician regarding transiently elevated blood sugars.
You have been prescribed Dilantin (Phenytoin) for anti-seizure medicine, take it as prescribed and follow up with laboratory blood drawing in one week.
